Advisory Committee to the Director, Centers for Disease Control and Prevention, 43694 [05-15019]

Download as PDF 43694 Federal Register / Vol. 70, No. 144 / Thursday, July 28, 2005 / Notices assistance to patients, doctors, and the general public. The ICA has over 20 years of achievement unmatched by any other health organization dealing with IC issues. Some of these achievements include: • Public awareness—the ICA has consistently attracted media attention to IC. Numerous articles featuring IC and the ICA have been published from the ‘‘New York Times,’’ ‘‘SELF Magazine,’’ ‘‘Good Housekeeping,’’ and many other national magazines. Subject-matter experts from the ICA have appeared on national TV and radio programs to include ABC’s ‘‘Good Morning America,’’ CNN, and National Public Radio. • Physician and Patient Education— Subject-matter experts from the ICA have published numerous articles on IC for professional journals including ‘‘Urology’’ and the ‘‘World Journal of Urology.’’ The ICA has worked closely with the NIDDK Division of Urology for over 15 years and has co-sponsored with the NIDDK, international scientific conferences as well as national IC patient meetings on IC biannually. ICA has also sponsored numerous regional educational programs for patients throughout the United States each year. • Patient Support—The ICA provides a toll-free 800 number designed to quickly assist both IC patients and healthcare providers. ICA also provides nationwide individual support via telephone and e-mail by ICA National Patient Support Advocates; the International IC Question Corner on its Web site, where patients can e-mail the ICA and receive one-on-one assistance with their questions; the ICA Physician Registry which helps IC patients find ICknowledgeable physicians; and IC connections, which brings together patients based on specific interests, concerns and regions, and an informational program on how to start new IC support groups. • Innovative resources—the ICA published, and continues to regularly update, a series of brochures and fact sheets as well as ‘‘IC Treatment Guidelines’’—the first comprehensive summary of IC treatments and medications designed for patients and their physicians for use as the basis for an individualized treatment plan. The ICA also publishes an on-line monthly ´ news digest, ‘‘Cafe ICA,’’ and two quarterly newsletters—the ‘‘ICA Update,’’ the only printed newsletter on IC in the United States, and the ‘‘ICA Physician Perspectives.’’ ICA also publishes a ‘‘Pocket Guide’’ series for continuing patient education. VerDate jul<14>2003 13:40 Jul 27, 2005 Jkt 205001 • Comprehensive Web Site—The ICA’s Web site http://www.icahelp.org, established in 1995, is the most comprehensive Web site on IC available today, receiving over 1.4 million hits per month. The site includes: a Clinical trials section, their on-line monthly ´ news digest—‘‘Cafe ICA,’’ IC Question Corner which provides one-on-one patient support, Treatment Options, a section for health care providers, a comprehensive research section, and much more * * *. • Non-profit leadership—the ICA remains the only United States 501 (c)(3) registered non-profit organization to fund IC research and provide educational programs on IC for both physicians and patients, as well as the public at large. This mission and ICA’s extensive network of resources and record of unmatched achievements over the last 20 years, makes it highly probable that ICA will successfully implement and complete all the required activities for this program announcement. For these reasons, the ICA is the only organization being considered for this program announcement. C. Funding Approximately $ 510,000 is available in FY 2005 to fund this award. It is expected that the award will begin on or before September 1, 2005, and will be made for a 12-month budget period within a project period of up to five years. Funding estimates may change. D. Where To Obtain Additional Information DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Advisory Committee to the Director, Centers for Disease Control and Prevention In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC) announces the following Advisory Committee meeting. Name: Advisory Committee to the Director, CDC. Time and Date: 8:30 a.m.–4:30 p.m., August 25, 2005. Place: Emory Conference Center, 1615 Clifton Road, Atlanta, Georgia 30329. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 75 people. Purpose: The committee will provide advice to the CDC Director on strategic and other broad issues facing CDC. Matters to Be Discussed: Agenda items will include updates on CDC priorities with discussions of program activities including updates on CDC scientific and programmatic activities, strategic imperatives, goals, research agenda, and health equity. Agenda items are subject to change as priorities dictate. Contact Person for More Information: Robert Delaney, Executive Secretary, Advisory Committee to the Director, CDC, 1600 Clifton Road, NE, M/S D–14, Atlanta, Georgia 30333. Telephone (404) 639–7000. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. For general comments or questions about this announcement, contact: Technical Information Management, CDC Procurement and Grants Office, 2920 Brandywine Road, Atlanta, GA 30341–4146; telephone: 770–488–2700. For technical questions about this program, contact: Richard S. Roman, Project Officer, HCAS/DACH/ NCCDPHP/CDC, 4770 Buford Hwy., N.E., MS K–51, Chamblee, GA 30341; telephone: 770–488–5144; e-mail: rsr1@cdc.gov. Dated: July 25, 2005. Diane Allen, Acting Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. 05–15019 Filed 7–27–05; 8:45 am] Dated: July 22, 2005. William P. Nichols, Director, Procurement and Grants Office, Centers for Disease Control and Prevention. [FR Doc. 05–14927 Filed 7–27–05; 8:45 am] Proposed Vaccine Information Materials for Hepatitis A and Influenza Vaccines; Interim Vaccine Information Materials for Influenza Vaccines BILLING CODE 4163–18–P PO 00000 Frm 00016 Fmt 4703 Sfmt 4703 BILLING CODE 4163–18–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Centers for Disease Control and Prevention (CDC), Department of Health and Human Services (HHS). ACTION: Notice with comment period. AGENCY: E:\FR\FM\28JYN1.SGM 28JYN1

Agencies

[Federal Register Volume 70, Number 144 (Thursday, July 28, 2005)]
[Notices]
[Page 43694]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-15019]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Advisory Committee to the Director, Centers for Disease Control 
and Prevention

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC) announces the following Advisory Committee meeting.

    Name: Advisory Committee to the Director, CDC.
    Time and Date: 8:30 a.m.-4:30 p.m., August 25, 2005.
    Place: Emory Conference Center, 1615 Clifton Road, Atlanta, 
Georgia 30329.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 75 people.
    Purpose: The committee will provide advice to the CDC Director 
on strategic and other broad issues facing CDC.
    Matters to Be Discussed: Agenda items will include updates on 
CDC priorities with discussions of program activities including 
updates on CDC scientific and programmatic activities, strategic 
imperatives, goals, research agenda, and health equity.
    Agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Robert Delaney, Executive 
Secretary, Advisory Committee to the Director, CDC, 1600 Clifton 
Road, NE, M/S D-14, Atlanta, Georgia 30333. Telephone (404) 639-
7000.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities, for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: July 25, 2005.
Diane Allen,
Acting Director, Management Analysis and Services Office, Centers for 
Disease Control and Prevention.
[FR Doc. 05-15019 Filed 7-27-05; 8:45 am]
BILLING CODE 4163-18-P